Treatment of Factitious Hyperthyroidism in Toxic Adenoma or Toxic Multinodular Goiter

Factitious hyperthyroidism occurring in the setting of a toxic adenoma or toxic multinodular goiter (TMNG) represents a specific clinical scenario that calls for a targeted, evidence-based management approach. The autonomous thyroid tissue driving excess hormone production shapes both the diagnostic workup and the choice of definitive intervention.

Clinical Scenario

This protocol applies to patients with factitious hyperthyroidism in the context of a toxic adenoma or toxic multinodular goiter — conditions characterised by autonomously functioning thyroid nodules producing excess thyroid hormone independent of TSH stimulation.

Management Approach (Summary)

The main treatment options for this scenario involve either an ablative or a surgical approach to address the autonomous thyroid tissue. In select patient populations, a long-term medical strategy may be considered as an alternative.

Complete regimen details, patient selection criteria, and sequencing are available in the full structured protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1089/thy.2016.0229

In toxic adenoma and multi-nodular goiter, radioactive ablation and thyroidectomy are the main treatment options.

Long-term treatment of toxic nodular goiter with anti-thyroid drugs might be indicated in some elderly or otherwise ill patients with limited life expectancy, who are not good candidates for surgery or ablative therapy or in patients who prefer this option.

View source ↗